For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?

Affiliations

¹ Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas.
² Division of Gastroenterology, Department of Medicine, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington; Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington.

Editorial

Amit G Singal et al. Clin Gastroenterol Hepatol. 2019 Aug.

. 2019 Aug;17(9):1732-1735.

doi: 10.1016/j.cgh.2019.02.020. Epub 2019 Feb 14.

¹ Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas.
² Division of Gastroenterology, Department of Medicine, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington; Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, Washington.

No abstract available

Comment on

Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
Farhang Zangneh H, Wong WWL, Sander B, Bell CM, Mumtaz K, Kowgier M, van der Meer AJ, Cleary SP, Janssen HLA, Chan KKW, Feld JJ. Farhang Zangneh H, et al. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1840-1849.e16. doi: 10.1016/j.cgh.2018.12.018. Epub 2018 Dec 20. Clin Gastroenterol Hepatol. 2019. PMID: 30580095

1. Kanwal F, Kramer J, Asch SM, et al. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology 2017;153:996–1005 e1. - PubMed
1. Singer AW, Reddy KR, Telep LE, et al. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study. Aliment Pharmacol Ther 2018. - PubMed
1. Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol 2018;68:25–32. - PMC - PubMed
1. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C, 2018. American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) Available at: http://www.hcvguidelines.org.
1. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018;68:723–750. - PubMed